Log in or Sign up for Free to view tailored content for your specialty!
Geriatrics News

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.
Top news of July: Permanent makeup, FDA approvals, tattoos, more

Healio has compiled July’s most-read news in dermatology.
Top news of June: Cancer risk, leaf extract, fungal infections, more

Healio has compiled June’s most-read news in dermatology.
Log in or Sign up for Free to view tailored content for your specialty!
Top news of April: Product rankings, counterfit Botox, solar eclipse

Healio has compiled April’s most-read news in dermatology.
Actinic keratosis incidence rates remain high in older populations

Actinic keratosis remains a public health problem for older adults, occurring in approximately three of every 10 Medicare recipients, according to a research letter published in JAMA Dermatology.
Nomacopan well tolerated in bullous pemphigoid treatment
Nomacopan was well tolerated and beneficial in patients with bullous pemphigoid, according to phase 2a clinical trial results.
Researchers organize bullous pemphigoid by three main profiles
Researchers identified three different clusters of bullous pemphigoid, the most common autoimmune blistering disorder, according to a study published in the Journal of American Academy of Dermatology.
Findings shed light on humoral response in gliptin-associated bullous pemphigoid
The humoral response to BP180 and BP230 antigens is weakened in certain patients with gliptin-associated bullous pemphigoid, according to a study.
Bullous pemphigoid increases cardiovascular disease mortality risk
Patients with bullous pemphigoid experienced increases in cardiovascular mortality risk at 1, 3 and 5 years compared with matched controls, according to a study.
Worldwide mortality rate high for bullous pemphigoid
A multi-continental meta-analysis showed high mortality rates for patients with bullous pemphigoid.
-
Headline News
Veterinarians had undetected bird flu infections, but such cases are rare, CDC says
February 19, 20252 min read -
Headline News
Semaglutide may raise risk for form of optic neuropathy in adults with type 2 diabetes
February 20, 20253 min read -
Headline News
CDC disease detectives ‘remain in their positions,’ agency says
February 20, 20253 min read
-
Headline News
Veterinarians had undetected bird flu infections, but such cases are rare, CDC says
February 19, 20252 min read -
Headline News
Semaglutide may raise risk for form of optic neuropathy in adults with type 2 diabetes
February 20, 20253 min read -
Headline News
CDC disease detectives ‘remain in their positions,’ agency says
February 20, 20253 min read